» Articles » PMID: 16943584

Postprandial Lipemia As a Risk Factor for Cardiovascular Disease in Patients with Hypothyroidism

Overview
Journal Endocrine
Specialty Endocrinology
Date 2006 Sep 1
PMID 16943584
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Postprandial lipoprotein metabolism is suggested to play a role in the pathogenesis of atherosclerosis. In this study, we investigated postprandial lipemia and its relationship to cardiovascular risk factors in patients with overt and subclinical hypothyroidism. Twenty-nine female patients with TSH levels greater than 5 microIU/mL and 12 euthyroid control female subjects were included in the study. Fifteen patients had subclinical hypothyroidism and 14 had overt hypothyroidism. All subjects underwent an oral lipid tolerance test. If triglyceride levels increased by 80% or more, subjects were considered postprandial lipemia positive. Control, overt hypothyroid, and subclinical hypothyroid groups were not statistically different with respect to anthropometric measurements, fasting blood C-reactive protein, uric acid, homocysteine, glucose, insulin, lipoprotein (a), apolipoprotein B levels, and homeostasis model assessment index. Fasting triglyceride levels correlated positively with TSH levels. Postprandial lipemia frequency was higher in overt hypothyroid subjects than in the control group. The subclinical hypothyroid group did not differ from the hypothyroid group with respect to postprandial lipemia frequency. In subjects with TSH levels higher than 5 microIU/mL, PPL risk was increased sevenfold. The results of this study show that postprandial triglyceride metabolism is affected in hypothyroidism.

Citing Articles

Carbohydrate-rich Meals Have no Impact on Post-prandial Lipid Parameters in Indians with Subclinical and Overt Primary Hypothyroidism.

Sharma L, Sharma N, Kulshreshtha B, Bansal R, Aggarwal A, Dutta D Eur Endocrinol. 2020; 16(2):161-166.

PMID: 33117450 PMC: 7572162. DOI: 10.17925/EE.2020.16.2.161.


A Population-Based Cohort Study on the Association of Hyperthyroidism With the Risk of Hyperlipidemia and the Effects of Anti-thyroid Drugs on Hepatic Gene Expression.

Wu T, Wang C, Tien N, Lin C, Chu F, Chang H Front Med (Lausanne). 2020; 7:228.

PMID: 32549042 PMC: 7273307. DOI: 10.3389/fmed.2020.00228.


Evolving data analysis of an Oral Lipid Tolerance Test toward the standard for the Oral Glucose Tolerance Test: Cross species modeling effects of AZD7687 on plasma triacylglycerol.

Gutierrez P, Yates J, Nilsson C, Birtles S Pharmacol Res Perspect. 2019; 7(2):e00465.

PMID: 30899516 PMC: 6408865. DOI: 10.1002/prp2.465.


A Renewed Focus on the Association Between Thyroid Hormones and Lipid Metabolism.

Duntas L, Brenta G Front Endocrinol (Lausanne). 2018; 9:511.

PMID: 30233497 PMC: 6129606. DOI: 10.3389/fendo.2018.00511.


Decreased expression of hepatic low-density lipoprotein receptor-related protein 1 in hypothyroidism: a novel mechanism of atherogenic dyslipidemia in hypothyroidism.

Moon J, Kim H, Kim H, Choi S, Lim S, Park Y Thyroid. 2013; 23(9):1057-65.

PMID: 23517243 PMC: 3770248. DOI: 10.1089/thy.2012.0457.


References
1.
Cohn J, McNamara J, Schaefer E . Lipoprotein cholesterol concentrations in the plasma of human subjects as measured in the fed and fasted states. Clin Chem. 1988; 34(12):2456-9. View

2.
Hokanson J, Austin M . Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996; 3(2):213-9. View

3.
Weintraub M, Grosskopf I, Trostanesky Y, Charach G, Rubinstein A, Stern N . Thyroxine replacement therapy enhances clearance of chylomicron remnants in patients with hypothyroidism. J Clin Endocrinol Metab. 1999; 84(7):2532-6. DOI: 10.1210/jcem.84.7.5812. View

4.
Ozcan O, Cakir E, Yaman H, Akgul E, Erturk K, Beyhan Z . The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism. Clin Endocrinol (Oxf). 2005; 63(2):203-6. DOI: 10.1111/j.1365-2265.2005.02326.x. View

5.
Hueston W, King D, Geesey M . Serum biomarkers for cardiovascular inflammation in subclinical hypothyroidism. Clin Endocrinol (Oxf). 2005; 63(5):582-7. DOI: 10.1111/j.1365-2265.2005.02388.x. View